Literature DB >> 14715365

A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis.

Samuel Z Goldhaber1, Victor F Tapson.   

Abstract

We enrolled 5,451 patients with ultrasound-confirmed deep vein thrombosis (DVT), including 2,892 women and 2,559 men, from 183 United States sites in our prospective registry. The 5 most frequent co-morbidities were hypertension (50%), surgery within 3 months (38%), immobility within 30 days (34%), cancer (32%), and obesity (27%). Of the 2,726 patients who had their DVT diagnosed while in the hospital, only 1,147 (42%) received prophylaxis within 30 days before diagnosis.

Entities:  

Mesh:

Year:  2004        PMID: 14715365     DOI: 10.1016/j.amjcard.2003.09.057

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  81 in total

1.  Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Susan R Kahn; Wendy Lim; Andrew S Dunn; Mary Cushman; Francesco Dentali; Elie A Akl; Deborah J Cook; Alex A Balekian; Russell C Klein; Hoang Le; Sam Schulman; M Hassan Murad
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

3.  Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution.

Authors:  Nicholas A Dewyer; Vikram Sood; Erin M Lynch; Catherine E Luke; Gilbert R Upchurch; Thomas W Wakefield; Steven Kunkel; Peter K Henke
Journal:  J Surg Res       Date:  2007-06-14       Impact factor: 2.192

4.  [Vena cava filter. Which indications remain in the era of differentiated anticoagulation?].

Authors:  A H Mahnken
Journal:  Radiologe       Date:  2013-03       Impact factor: 0.635

5.  Venous thromboembolism prophylaxis in the United States: still room for improvement.

Authors:  Diane Sliwka; Margaret C Fang
Journal:  J Gen Intern Med       Date:  2010-06       Impact factor: 5.128

6.  Cancer-associated thrombosis.

Authors:  Mehran Karimi; Nader Cohan
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

7.  The effects of sleep hypoxia on coagulant factors and hepatic inflammation in emphysematous rats.

Authors:  Jing Feng; Qing-shan Wang; Ambrose Chiang; Bao-yuan Chen
Journal:  PLoS One       Date:  2010-10-06       Impact factor: 3.240

8.  Assessment of risk and prophylaxis for deep vein thrombosis and pulmonary embolism in medically ill patients during their early days of hospital stay at a tertiary care center in a developing country.

Authors:  Ambarish Pandey; Nivedita Patni; Mansher Singh; Randeep Guleria
Journal:  Vasc Health Risk Manag       Date:  2009-08-06

9.  Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts.

Authors:  Greg Maynard; Jason Stein
Journal:  J Thromb Thrombolysis       Date:  2010-02       Impact factor: 2.300

10.  Prevention and treatment of venous thromboembolism in the elderly patient.

Authors:  Enrico Tincani; Mark A Crowther; Fabrizio Turrini; Domenico Prisco
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.